Clinical Trial

Tapering of Biologics in Chronic Rhinosinusitis With Nasal Polyps

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this study is to investigate the feasibility of extending the dosing intervals of biological therapies while maintaining optimal treatment effects in chronic rhinosinusitis with nasal polyps (CRSwNP).
Trial Details
NCT Number NCT07187583
Lead Sponsor Rigshospitalet, Denmark
Conditions Chronic Rhinosinusitis With Nasal Polyps
Enrollment 135 participants
Start Date 2025-06-05
Primary Completion 2028-03-01 (estimated)
Study Completion 2028-03-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-23